Next generation medical therapy for Cushing's syndrome--can we measure a benefit?
The Christie NHS Foundation Trust, Manchester M20 4BX, United Kingdom.
Peter J
PJ
Trainer
D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000652:urine*; D007093:Imidazoles / Q000627:therapeutic use*; D008297:Male; D047748:Pituitary ACTH Hypersecretion / Q000188:drug therapy* / Q000652:urine*; D011725:Pyridines / Q000627:therapeutic use*; D013252:Steroid 11-beta-Hydroxylase / Q000037:antagonists & inhibitors*
D007093:Imidazoles; D011725:Pyridines; C553306:Osilodrostat; D013252:Steroid 11-beta-Hydroxylase; D006854:Hydrocortisone